| 发明名称 |
PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS |
| 摘要 |
The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis. |
| 申请公布号 |
US2017065571(A1) |
申请公布日期 |
2017.03.09 |
| 申请号 |
US201615356766 |
申请日期 |
2016.11.21 |
| 申请人 |
KAHRS BJOERN COLIN |
发明人 |
KAHRS BJOERN COLIN |
| 分类号 |
A61K31/4439;A61K31/225;A61K9/00 |
主分类号 |
A61K31/4439 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating multiple sclerosis in a patient, comprising the co-administration of therapeutically effective amounts of an Nrf2 activator selected from the group of fumaric acid esters and salts thereof and a PPAR gamma agonist selected from the group of glitazones and its salt forms to said patient. |
| 地址 |
COLLONGE-BELLERIVE CH |
